55 results
Page 2 of 3
8-K
EX-10.1
7ynnz56a
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
424B5
8kxwm8
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
r5fiy72b2fk
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
j68lib
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
9ybggw ns
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
4i7x m90ta1
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
e3fdqmh6
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
b5ze4
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-10.1
pyr1yv
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
yzvra71z2 gcj9oyxz
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
EX-10.1
1ot1f3bhv
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-10.4
bdcvh5psfs17gam73oqi
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.1
s9v9wf4x
27 Jun 19
Departure of Directors or Certain Officers
8:08am